全球抗球虫药物市场 – 行业趋势及 2030 年预测

抗球虫药物市场分析及规模

近年来，人们越来越多地将宠物，包括狗、猫甚至马，作为人类的伴侣。Kingsdale 动物医院 2022 年 1 月公布的数据显示，球虫是狗中最常见的肠道寄生虫之一，狗中球虫的发生率为 50%，发病率各不相同。

Data Bridge Market Research 分析了 2023-2030 年预测期内全球抗球虫药物市场的增长率。在上述预测期内，全球抗球虫药物市场的预期复合年增长率趋于 9.2% 左右。2022 年市场价值为 12.4248 亿美元，到 2030 年将增长至 31.0395 亿美元。除了市场价值、增长率、细分市场、地理覆盖范围、市场参与者和市场情景等市场洞察外，Data Bridge Market Research 团队策划的市场报告还包括深入的专家分析、患者流行病学、渠道分析、定价分析和监管框架。

抗球虫药物市场范围和细分

Market Definition

Coccidiosis is caused due to single-celled parasites (protozoa) called Eimeria, which undergo a simple gut life cycle. Any such drug which is used to combat the progression of coccidiosis in birds or animals, both non-food producing and food-producing, is known as an anticoccidial.  Its symptoms include weight loss, feces containing mucus or blood, dehydration, mild intermittent to severe diarrhea, and decreased breeding.

Global Anti-Coccidial Drugs Market Dynamics

Drivers

• Increasing share of animal ownership

Due to the promising economic condition, the highly developed economies represent a major large share of companion animal ownership. For instance, the Pet Food Manufacturers Association reported that in 2021, 17 million (59% of) households in the U.K. owned pets. These pet owners are more worried and aware of the safety of their pets. This creates an opportunity to diagnose fungal and bacterial diseases such as coccidiosis, which is an infection that is caused by the fungus coccidioides immitis among animals. This is projected to contribute to the overall market growth during the forecast period.  

• Rising expenditure on pet healthcare

Pet owners are investing in their pets hugely, such as in health insurance for pets, leading to rising expenditure on their health, thus acting as a major driver for market growth. For instance, according to the North American Pet Health Insurance Association (NAPHIA), around 4.41 million pets were insured in North America at the end of 2021. Furthermore, as per American Pet Products Association, USD 123.6 billion was spent on pets and animals in the U.S. in 2021, which augmented from about USD 99.0 billion in 2020. This expenditure by pet owners is likely to boost market growth over the forecast period.

Opportunities

• The growing burden of coccidiosis in target animals

The wide prevcalence of coccidiosis among the target animals of specific age demands the wide availability of the anticoccidial drugs. For instance, Eimeria is a genus of apicomplexan parasites, that includes several species capable of causing the disease coccidiosis in animals such as dogs, cattle, poultry, cats, and smaller ruminants such as sheep and goats. According to the research article "Coccidiosis of Cattle" published in August 2022, approximately 20 or more Eimeria species have been identified in cattle feces worldwide. Thus, this factor creates more opportunities for market growth.

• Increasing prevalence of isospora species

According to the Merck and Co. Inc. data updated in August 2022 on "Coccidiosis of Cats and Dogs", the isospora species is a common coccidiosis of cats and dogs. Approximately every cat gets infected by isospora felis in its lifetime. Moreover, as per the source mentioned above, coccidiosis usually occurs in young animals in facilities with potential contamination and  high population. Thus, this disease may become a problem in breeding or boarding catteries and kennels. This burden of coccidiosis among companion animals creates many different opportunities for developing anticoccidial drugs. This is projected to contribute to segment growth.

 Restraints/Challenges

• Limited studies and surveys

There are very limited studies and surveys that are hampering the growth of the market. Not many studies and awareness have been spread about this disease, and thus, this hampers the market's growth.

• High cost of drugs

The huge expenditure associated with anti-coccidial medications hampers the market growth. Different polyether antibiotics or ionophores, combination anti-coccidial drugs are of high cost which restricts the growth of the market.

This global anti-coccidial drugs market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global anti-coccidial drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Anti-Coccidial Drugs Market

The outbreak of COVID-19 showed an adverse impact on the global anti-coccidial drugs market . According to the article "The Initial Months of COVID-19: Dog Owners' Veterinary-Related Concerns," published in February 2021, dog owners feared that COVID-19 infection might lead to a decrease in disease diagnoses for pets. Moreover, the study showed that like many other professions, veterinarians were majorly impacted by the onset of COVID-19 in the initial phase of the pandemic. Thus, standard practices such as routine animal checkups, diagnoses, and surgeries were disturbed. These reduced services lowered the coccidiosis diagnosis, therefore, hampering the market growth.

But, in the post-pandemic era, poultry consumption and the adoption of companion animals increased. This led to a higher demand for diagnosis of poultry coccidiosis and companion animal coccidiosis. Thus, on the basis of above factors, the COVID-19 pandemic considerably impacted the market.

Recent Developments:

• In March 2022, Amlan International developed two new natural alternatives to antibiotics for poultry and livestock, such as Phylox Feed and NeutraPath. Phylox Feed is a natural alternative to anticoccidial drugs and vaccines, that can help producers to increase profitability.

Global Anti-Coccidial Drugs Market Scope

The global anti-coccidial drugs market is segmented on the basis of type, animals, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Synthetic Drugs
• Polyether Antibiotics or Ionophores
• Combination Anti-Coccidial Drugs
• Others

Animals

• Swine
• Fish
• Cattle
• Poultry
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Anti-Coccidial Drugs Market Regional Analysis/Insights

The global anti-coccidial drugs market is analysed and market size insights and trends are provided by type, animals, distribution channel and end-user as referenced above.

The major countries covered in the global anti-coccidial drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing positive growth for the global anticoccidial drugs market throughout the forecasted period due to increased healthcare and R&D expenditure and the presence of skilled professionals.

Asia-Pacific dominates the market due to increased poultry farming and increased awareness for anti-coccidial drugs through advertisement and media and rapidly improving healthcare infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Anti-coccidial Drugs Market Share Analysis

全球抗球虫药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对全球抗球虫药物市场的关注有关

全球抗球虫药物市场的主要参与者包括：

• Impextraco NV (比利时)
• Vetoquinol（法国）
• Phibro 动物保健公司（美国）
• Huvepharma（保加利亚）
• 维克（法国）
• 拜耳公司（德国）
• 默克公司（美国），
• 诺华公司（瑞士）。
• 硕腾 (美国)
• Elanco (美国)
• Ceva（法国）。
• ProBioGen AG（德国）

SKU-56336